This study aimed to better estimate the risk of progression of vaginal intraepithelial neoplasia (VaIN) into vaginal cancer.
Method:
A systematic review was conducted to identify eligible studies that (1) reported at least one event of progression from VaIN to vaginal cancer, (2) provided the VaIN grade, (3) had a follow-up period of at least 6 months, and (4) specified the proportion of treated and untreated patients. The effect size was the risk of progression from VaIN to invasive cancer, calculated as the number of events of progression out of all the observed cases at enrolment.
Results:
Five thousand seven hundred and sixty-eight references were screened; 30 case series were deemed eligible for qualitative analysis. Twenty case series of treated women, and four case series of untreated women were quantitatively analyzed. Both subgroups included cases of high-grade VaINs (no progressions to vaginal cancer found in low-risk VaINs). A sensitivity analysis on the subgroup of untreated women resulted in the exclusion of a study with excessive influence, with the final data synthesis based on three poor-quality case series. The risk of progression of high-grade VaIN to vaginal cancer in treated women was 7.09% (95% confidence interval [CI]: 6.83–7.36%). The risk of progression of high-grade VaIN to vaginal cancer in untreated women was 29.88% (95% CI: 11.22–58.96%). Progression events primarily occurred within 5 years of follow-up.
Conclusion:
The risk of progression of high-grade VaIN to vaginal cancer is higher than previously reported and more serious for untreated women (CRD42024618227).
CardosiRJ, BomalaskiJJ, HoffmanMS. Diagnosis and management of vulvar and vaginal intraepithelial neoplasia. Obstet Gynecol Clin North Am2001;28(4):685–702; doi: 10.1016/s0889-8545(05)70229-1
2.
SillmanFH, FruchterRG, ChenYS, et al.Vaginal intraepithelial neoplasia: Risk factors for persistence, recurrence, and invasion and its management. Am J Obstet Gynecol1997;176(1 Pt 1):93–99; doi: 10.1016/s0002-9378(97)80018-x
3.
SopracordevoleF, BarberoM, ClementeN, Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV). et al.; High-grade vaginal intraepithelial neoplasia and risk of progression to vaginal cancer: A multicentre study of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV). Eur Rev Med Pharmacol Sci2016;20(5):818–824.
4.
IndraccoloU, BorghiC, Mattei GentiliM, et al.Natural history of primary vaginal intraepithelial neoplasia with and without treatment: A systematic review and meta-analysis. Clin Exp Obstet Gynecol2025;52(8):3677; doi: 10.31083/CEOG36377
5.
KesicV, CarcopinoX, PretiM, et al.The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus Statement on the management of vaginal intraepithelial neoplasia. J Low Genit Tract Dis2023;27(2):131–145; doi: 10.1097/LGT.0000000000000732
6.
IndraccoloU, ChiavariniM, FavilliA, et al.A practical method for remedying some biased data sets: Looking for fractal traces. Mat Stat Eng App2023;72:1653–1670.
7.
AhoM, VesterinenE, MeyerB, et al.Natural history of vaginal intraepithelial neoplasia. Cancer1991;68(1):195–197; doi: 10.1002/1097-0142(19910701)68:1<195::aid-cncr2820680135>3.0.co;2-l
8.
BoganiG, DittoA, MartinelliF, et al.LASER treatment for women with high-grade vaginal intraepithelial neoplasia: A propensity-matched analysis on the efficacy of ablative versus excisional procedures. Lasers Surg Med2018;50(9):933–939; doi: 10.1002/lsm.22941
9.
DongH, LiH, WangL, et al.Clinical analysis of 175 cases of vaginal intraepithelial neoplasia. Eur J Obstet Gynecol Reprod Biol2023;287:232–236; doi: 10.1016/j.ejogrb.2023.06.020
10.
FregaA, FrenchD, PiazzeJ, et al.Prediction of persistent vaginal intraepithelial neoplasia in previously hysterectomized women by high-risk HPV DNA detection. Cancer Lett2007;249(2):235–241; doi: 10.1016/j.canlet.2006.09.003
11.
GallupDG, MorleyGW. Carcinoma in situ of the vagina. A study and review. Obstet Gynecol1975;46:334–340.
12.
GeelhoedGW, HensonDE, TaylorPT, et al.Carcinoma in situ of the vagina following treatment for carcinoma of the cervix: A distinctive clinical entity. Am J Obstet Gynecol1976;124(5):510–516; doi: 10.1016/0002-9378(76)90179-4
13.
Gonzalez-SanchezJL, Flores-MurrietaG, Deolarte-MelgarejoJM, et al.Effectiveness of 5-Fluorouracil in the treatment of vaginal intraepithelial neoplasia in a mexican population. J Low Genit Tract Dis1998;2(4):221–224; doi: 10.1097/00128360-199810000-00007
14.
GrahamK, WrightK, CadwalladerB, et al.20-year retrospective review of medium dose rate intracavitary brachytherapy in VAIN3. Gynecol Oncol2007;106(1):105–111; doi: 10.1016/j.ygyno.2007.03.005
15.
GundersonCC, NugentEK, ElfrinkSH, et al.A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia. Am J Obstet Gynecol2013;208(5):410.e1-6–410.e6; doi: 10.1016/j.ajog.2013.01.047
16.
HeMY, YuEL, HuiSK, et al.Clinical outcomes of laser vaporization for vaginal intraepithelial neoplasia—A 20-year retrospective review. Eur J Obstet Gynecol Reprod Biol2022;277:101–109; doi: 10.1016/j.ejogrb.2022.08.017
17.
HodeibM, CohenJG, MehtaS, et al.Recurrence and risk of progression to lower genital tract malignancy in women with high grade VAIN. Gynecol Oncol2016;141(3):507–510; doi: 10.1016/j.ygyno.2016.03.033
18.
JentschkeM, HoffmeisterV, SoergelP, et al.Clinical presentation, treatment and outcome of vaginal intraepithelial neoplasia. Arch Gynecol Obstet2016;293(2):415–419; doi: 10.1007/s00404-015-3835-6
19.
KimMK, LeeIH, LeeKH. Clinical outcomes and risk of recurrence among patients with vaginal intraepithelial neoplasia: A comprehensive analysis of 576 cases. J Gynecol Oncol2018;29(1):e6; doi: 10.3802/jgo.2018.29.e6
LiaoJB, JeanS, Wilkinson-RyanI, et al.Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: A clinically recalcitrant entity. Gynecol Oncol2011;120(1):108–112; doi: 10.1016/j.ygyno.2010.09.005
22.
MacLeodC, FowlerA, DalrympleC, et al.High-dose-rate brachytherapy in the management of high-grade intraepithelial neoplasia of the vagina. Gynecol Oncol1997;65(1):74–77; doi: 10.1006/gyno.1996.4608
23.
MurakamiK, NakaiH, AokiM, et al.Ultrasonic scalpel ablation for vaginal intraepithelial neoplasia occurring after hysterectomy. Eur J Gynaecol Oncol2017;38:541–546; doi: 10.12892/ejgo3572.2017
24.
PerrottaM, MarchitelliCE, VelazcoAF, et al.Use of CO2 laser vaporization for the treatment of high-grade vaginal intraepithelial neoplasia. J Low Genit Tract Dis2013;17(1):23–27; doi: 10.1097/LGT.0b013e318259a3ec
25.
PetrilliES, TownsendDE, MorrowCP, et al.Vaginal intraepithelial neoplasia: Biologic aspects and treatment with topical 5-fluorouracil and the carbon dioxide laser. Am J Obstet Gynecol1980;138(3):321–328; doi: 10.1016/0002-9378(80)90256-2
26.
RatnaveluN, PatelA, FisherAD, et al.High-grade vaginal intraepithelial neoplasia: Can we be selective about who we treat? BJOG2013;120(7):887–893; doi: 10.1111/1471-0528.12223
RomeRM, EnglandPG. Management of vaginal intraepithelial neoplasia: A series of 132 cases with long-term follow-up. Int J Gynecol Cancer2000;10(5):382–390; doi: 10.1046/j.1525-1438.2000.010005382.x
29.
ShenF, SunSG, ZhangXY, et al.Clinical outcomes of vaginectomy and laser ablation for the treatment of post-hysterectomy women with vaginal high-grade squamous intraepithelial lesions: A retrospective study. Eur J Obstet Gynecol Reprod Biol2020;248:71–76; doi: 10.1016/j.ejogrb.2020.03.017
30.
StuartGC, FlaglerEA, NationJG, et al.Laser vaporization of vaginal intraepithelial neoplasia. Am J Obstet Gynecol1988;158(2):240–243; doi: 10.1016/0002-9378(88)90130-5
31.
WoodmanCB, JordanJA, Wade-EvansT. The management of vaginal intraepithelial neoplasia after hysterectomy. Br J Obstet Gynaecol1984;91(7):707–711; doi: 10.1111/j.1471-0528.1984.tb04835.x
32.
YuD, QuP, LiuM. Clinical presentation, treatment, and outcomes associated with vaginal intraepithelial neoplasia: A retrospective study of 118 patients. J Obstet Gynaecol Res2021;47(5):1624–1630; doi: 10.1111/jog.14733
33.
GallioN, PretiM, BoldoriniR, et al.High-grade vaginal intraepithelial neoplasia: Clinical profile, HPV vaccination status, and treatment outcomes at two Italian Referral Centers. Vaccines (Basel)2025;13(11):1089; doi: 10.3390/vaccines13111089
34.
McCredieMR, SharplesKJ, PaulC, et al.Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: A retrospective cohort study. Lancet Oncol2008;9(5):425–434; doi: 10.1016/S1470-2045(08)70103-7
35.
LoopikDL, BentleyHA, EijgenraamMN, et al.The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: A systematic review and meta-analysis. J Low Genit Tract Dis2021;25(3):221–231; doi: 10.1097/LGT.0000000000000604
36.
KimHS, ParkNH, ParkIA, et al.Risk factors for recurrence of vaginal intraepithelial neoplasia in the vaginal vault after laser vaporization. Lasers Surg Med2009;41(3):196–202; doi: 10.1002/lsm.20741
37.
YalcinOT, RutherfordTJ, ChambersSK, et al.Vaginal intraepithelial neoplasia: Treatment by carbon dioxide laser and risk factors for failure. Eur J Obstet Gynecol Reprod Biol2003;106(1):64–68; doi: 10.1016/s0301-2115(02)00209-9
38.
DodgeJA, EltabbakhGH, MountSL, et al.Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia. Gynecol Oncol2001;83(2):363–369; doi: 10.1006/gyno.2001.6401
